These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 446508

  • 1. Relationship between the severity of renal stone disease and urine composition.
    Tiselius HG.
    Eur Urol; 1979; 5(5):323-7. PubMed ID: 446508
    [Abstract] [Full Text] [Related]

  • 2. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG, Larsson L.
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [Abstract] [Full Text] [Related]

  • 3. A biochemical basis for grouping of patients with urolithiasis.
    Tiselius HG, Almgård LE, Larsson L, Sörbo B.
    Eur Urol; 1978; 4(4):241-9. PubMed ID: 668734
    [Abstract] [Full Text] [Related]

  • 4. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG, Peacock M, Nordin BE.
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract] [Full Text] [Related]

  • 5. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I.
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [Abstract] [Full Text] [Related]

  • 6. [Questionable significance of the chemical analysis of a single 24-hour urine sample in recurrent calcium oxalate nephrolithiasis].
    Riess C, Hess B, Binswanger U.
    Klin Wochenschr; 1986 May 02; 64(9):411-6. PubMed ID: 3713110
    [Abstract] [Full Text] [Related]

  • 7. Circadian variations of blood and urinary constituents in renal stone formers.
    Singh RK, Bansal A, Bansal SK, Rai SP.
    Prog Clin Biol Res; 1990 May 02; 341B():551-7. PubMed ID: 2217342
    [No Abstract] [Full Text] [Related]

  • 8. Urine composition in patients with urolithiasis during treatment with magnesium oxide.
    Tiselius HG, Ahlstrand C, Larsson L.
    Urol Res; 1980 May 02; 8(4):197-206. PubMed ID: 7222314
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B, Gambaro G, Favaro S, Borsatti A.
    Nephron; 1983 May 02; 35(1):11-4. PubMed ID: 6888620
    [Abstract] [Full Text] [Related]

  • 10. The loss of circadian rhythmicity of urinary solute excretion in idiopathic stone formers.
    Sidhu H, Vaidyanathan S, Wangoo D, Thind SK, Nath R, Malakondaiah GC, Krishan K.
    Br J Urol; 1989 Oct 02; 64(4):333-5. PubMed ID: 2819381
    [Abstract] [Full Text] [Related]

  • 11. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1987 Sep 02; 33(9):1321-30. PubMed ID: 3434487
    [Abstract] [Full Text] [Related]

  • 12. Urinary factors of kidney stone formation in patients with Crohn's disease.
    Böhles H, Beifuss OJ, Brandl U, Pichl J, Akçetin Z, Demling L.
    Klin Wochenschr; 1988 Feb 01; 66(3):87-91. PubMed ID: 3352194
    [Abstract] [Full Text] [Related]

  • 13. Body size and 24-hour urine composition.
    Taylor EN, Curhan GC.
    Am J Kidney Dis; 2006 Dec 01; 48(6):905-15. PubMed ID: 17162145
    [Abstract] [Full Text] [Related]

  • 14. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M, Anders D, Graef V, Bödeker RH.
    Monatsschr Kinderheilkd; 1985 Oct 01; 133(10):754-9. PubMed ID: 4069117
    [Abstract] [Full Text] [Related]

  • 15. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E, Imperiali P, Badii M, Capiccioni S, Masi MG, Sasdelli M.
    Proc Eur Dial Transplant Assoc; 1983 Oct 01; 20():445-9. PubMed ID: 6657667
    [Abstract] [Full Text] [Related]

  • 16. A case-control study of dietary intake of renal stone patients. II. Urine biochemistry and stone analysis.
    Griffith HM, O'Shea B, Maguire M, Koegh B, Kevany JP.
    Urol Res; 1986 Oct 01; 14(2):75-82. PubMed ID: 3727218
    [Abstract] [Full Text] [Related]

  • 17. Validity of biochemical findings in the evaluation of patients with urolithiasis.
    Tiselius HG, Larsson L.
    Eur Urol; 1980 Oct 01; 6(2):90-4. PubMed ID: 7358065
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of factors involved in calcium stone formation.
    Abraham PA, Smith CL.
    Miner Electrolyte Metab; 1987 Oct 01; 13(3):201-8. PubMed ID: 3627051
    [Abstract] [Full Text] [Related]

  • 19. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E.
    Invest Urol; 1975 Jan 01; 12(4):251-4. PubMed ID: 1112654
    [Abstract] [Full Text] [Related]

  • 20. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H, Suzuki F, Yamaguchi K, Nishikawa Y, Kotake T.
    Clin Nephrol; 1992 Jan 01; 37(1):14-8. PubMed ID: 1541059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.